Market Tracker

10/02 4:10am ET

Gilead Sciences Inc (NASDAQ:GILD)

105.59
Data as of Oct 01
 -0.86 / -0.81%
Today’s Change
58.81
Today|||52-Week Range
110.64
+40.60%
Year-to-Date

Today’s Trading

Previous close106.45
Today’s open106.99
Day’s range105.19 - 107.59
Volume11,659,388
Average volume (3 months)13,686,567
Market cap$160.9B
Dividend yield--
Data as of 3:59pm ET, 10/01/2014

Growth & Valuation

Earnings growth (last year)+10.37%
Earnings growth (this year)+294.41%
Earnings growth (next 5 years)+17.10%
Revenue growth (last year)+16.72%
P/E ratio23.7
Price/Sales10.23
Price/Book14.37

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen Inc-1.64-1.17%
BIIBBiogen Idec Inc-7.31-2.21%
BAXBaxter International...-0.26-0.36%
----
Data as of 10/01/2014

Financials

Next reporting dateOctober 21, 2014
EPS forecast (this quarter)$1.92
Annual revenue (last year)$11.2B
Annual profit (last year)$3.1B
Net profit margin27.40%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John C. Martin
President &
Chief Operating Officer
John F. Milligan
Corporate headquarters
Foster City, California

Forecasts